In this study, we investigated the transformation of atenolol (ATL) by the naturally occurring laccase from Trametes versicolor in aqueous solution. Removal efficiency of ATL via laccase-catalyzed reaction in the presence of various laccase mediators was examined, and found that only the mediator 2, 2, 6, 6-tetramethyl-1-piperidinyloxy (TEMPO) was able to greatly promote ATL transformation. The influences of TEMPO concentration, laccase dosage, as well as solution pH and temperature on ATL transformation efficiency were tested. As TEMPO concentrations was increased from 0 to 2000 μM, ATL transformation efficiency first increased and then decreased, and the optimal TEMPO concentration was determined as 500 μM. ATL transformation efficiency was gradually increased with increasing laccase dosage. ATL transformation was highly pH-dependent with an optimum pH of 7.0, and it was almost constant over a temperature range of 25-50 °C. Humic acid inhibited ATL transformation through competition reaction with laccase. The presence of anions HCO and CO reduced ATL transformation due to both anions enhanced solution pHs, while Cl, SO, and NO at 10 mM showed no obvious influence. The main transformation products were identified, and the potential transformation pathways were proposed. After enzymatic treatment, the toxicity of ATL and TEMPO mixtures was greatly reduced. The results of this study might present an alternative clean strategy for the remediation of ATL contaminated water matrix.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ecoenv.2019.109555 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
New treatments for adult T-cell leukemia/lymphoma.
Leuk Res
January 2025
Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 E 74th St., New York, NY 10021, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA. Electronic address:
Adult T cell leukemia lymphoma (ATL) is a mature T cell neoplasm caused by human T-cell lymphotropic virus type 1 (HTLV-1). ATL is endemic in specific geographic regions of the world closely related to areas with high prevalence of HLTV-1 infection, including Southwestern Japan, the Caribbean Basin, Central Africa, South America, Northern and Central Australia. HLTV-1 is primarily transmitted through breastmilk in asymptomatic carriers with a long latency period before transformation into ATL in 3 - 5 % of carriers after acquisition of multiple leukemogenic mutations.
View Article and Find Full Text PDFCharacterization of HTLV-1 Infectious Molecular Clone Isolated from Patient with HAM/TSP and Immortalization of Human Primary T-Cell Lines.
Viruses
November 2024
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
Article Synopsis
- HTLV-1 is linked to diseases like adult T-cell leukemia and HTLV-1-associated myelopathy, prompting researchers to isolate a molecular clone from a patient with HAM/TSP.
- This clone exhibits unique genetic features and viral mRNA patterns, indicating a potential connection to the development of HAM/TSP.
- The study finds that while direct infection of primary T cells with HTLV-1 clones leads to limited cell growth, transmission from dendritic cells enhances long-term proliferation and supports latent infections.
Investigation of the dissolution rate and oral bioavailability of atenolol-irbesartan co-amorphous systems.
Int J Pharm
November 2024
Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China. Electronic address:
Article Synopsis
- * In this study, IBS was combined with atenolol (ATL) using melt-quenching in various ratios, resulting in ATL-IBS CAMs that showed significantly better dissolution than regular IBS.
- * The ATL-IBS CAM not only maintained greater supersaturation and showed strong physical stability but also resulted in a 2.78-fold increase in oral bioavailability compared to standard IBS when tested on rats.
Viral antigen mismatch affects antiviral T-cell response and may impair immunotherapeutic efficacy against adult T-cell leukemia/lymphoma.
J Infect Dis
September 2024
Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Article Synopsis
- - HTLV-1 can quickly transform CD4+ T cells in a lab setting, but most infected people remain asymptomatic, indicating a balance between the virus and the host's immune response.
- - The study found a variant in the HTLV-1 Tax301-309 viral antigen in individuals with a specific HLA-A24 type, which affected the detection of anti-Tax cytotoxic T cells (CTLs).
- - More than half of the T-cell receptors (TCRs) from these anti-Tax CTLs failed to recognize the mismatched Tax301-309 peptides, underlining the need for precise matching of viral antigens in T-cell therapy for adult T-cell leukemia (ATL).
Turning Waste into Treasure: Invasive Plant Leaves as a High-Efficiency Inhibitor for Steel in Simulated Pickling Solutions.
Materials (Basel)
July 2024
Key Laboratory of Advanced Marine Materials, Key Laboratory of Marine Environmental Corrosion and Bio-Fouling, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
Article Synopsis
- Traditional corrosion inhibitors are highly toxic, prompting the search for safer, eco-friendly alternatives like the extract from invasive plant leaves found in China.
- The extract, known as ATL, is made using a simple water-based method and contains beneficial heterocyclic organics, making it a promising green corrosion inhibitor.
- Electrochemical tests show ATL can achieve up to 99% inhibition efficiency, indicating its effectiveness in protecting steel surfaces, suggesting potential for use in industrial applications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!